Business
MustGrow Completes Initial Commercial Production Run via Contract Manufacturer
Succesful completion of initial commercial run-rate production via third-party contract manufactu...
About this update from Mustgrow Biologics Corp.
[{"type":"text","content":"MustGrow Completes Initial Commercial Production Run via Contract ManufacturerSuccesful completion of initial commercial run-rate production via third-party contract manufacturer.Production run-rate of the extract reached greater than the equivalent of 5,000 litres per day of MustGrow's mustard plant-based biocontrol liquid technology. Estimated equivalent annual capacity equates to approximately US$25 million in grower level revenue without the need to construct capital intensive production facilities.Saskatoon, Saskatchewan--(Newsfile Corp. - June 13, 2023) -  MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the \"Company\" or \"MustGrow\"), is pleased to announce the successful initial commercial run-rate production of its mustard plant-based biocontrol liquid via a contract manufacturer. MustGrow believes this production milestone further validates the Company's commercialization strategy to initially utilize a third party contract manufacturer rather than construct its own capital-intensive pilot and/or commercial production facilities. The continuous production run-rate of the extract reached greater than the equivalent of 5,000 litres per day of MustGrow's mustard plant-based biocontrol liquid technology, which is estimated to equal approximately US$25 million in annual grower level revenue. The production process created zero residual waste by generating a high protein byproduct ingredient for animal feed.MustGrow's CEO, Corey Giasson noted: \"This is a key transition for MustGrow, now able to complete our first commercial-level production without needing to build our own capital-intensive facility. We are now confident that we will be capable of producing commercially-scalable quantities of TerraSanteTM and TerraMGTM in preparation for initial registration approvals. The continuous-flow design process ran without any reported upsets and we are close to maximum theoretical recovery of our targeted mustard extracts in the concentrate. This milestone successfully demonstrates a low-risk continuous-flow process, while further mitigating commercialization risk.\"Utilizing a third party contract manufacturer markedly derisks commercial capabilities in MustGrow's soil amendment and biofertility technologies, as well as biocontrol and postharvest food preservation, which are currently under development with...